Renner 2001 [] 3 months placebo 6 months 24 No specific inclusion. Range: 6.7-27.7 years. Plasma β-carotene β-carotene, 1 mg/kg/d (maximum total antioxidant 50) + 3 months 10 capacity, antibiotics, mg/day. Shwachmann score, BMI, height, MDA, pulmonary function. Gottrand 1999 [] Enteral diet, "high fat" Enteral diet, "normal 4 weeks 8 Receiving nighttime Range: 6-19 years. Pulmonary function, 33/67 non protein fat" 60/40 non enteral nutrition for substrate oxidation, energy glucose to fat protein energy month before the energy intake, ≥1 ratio. glucose to fat ratio. study. tolerance Beker 1997 [] 5 mg/week oral no supplementation 4 weeks 18 Stable, afebrile, Range: 13-35 years. Plasma vitamin K1, vitamin K1. without cholestasis/ vitamin overt liver disease, PIVKA-II, normal AST/ALT, serum Osteocalcin, normal albumin. urinary GLA Van Egmond 1996 Predigested formula Predigested formula Not clear 76 Diagnosed by 9 mo, year Anthropometrics ≥1 [] with 12% linoleic acid. with 7% linoleic acid. formula providing > 10% of intake Stark 1995 [] Nutritional standard care 6 weeks 9 No specific inclusion. Range: 2-6 years. Calorie intake, weight education+ mealtime gain behaviors. Kurlandsky 1994 [] N-3 (menhaden oil N-6 (safflower oil 6 weeks 14 Ability to Range: 6-16 years. Absorption and 100-131 mg/kg/day, mg/kg/day, mean pulmonary function + clinical effects of n-3 mean 112.8). 113.3). swallow capsules. vs. n-6 fatty acids
Renner 2001 [] 3 months β-carotene 1 mg/kg/d (maximum 50) + 3 months 10 mg/day. placebo 6 months 24 No specific inclusion. Range: 6.7-27.7 years. Plasma β-carotene, total antioxidant capacity, antibiotics, Shwachmann score, BMI, height, MDA, pulmonary function. Gottrand 1999 [] Enteral diet, "high fat" 33/67 non protein energy glucose to fat ratio. Enteral diet, "normal fat" 60/40 non protein energy glucose to fat ratio. 4 weeks 8 Receiving nighttime enteral nutrition for ≥1 month before the study. Range: 6-19 years. Pulmonary function, substrate oxidation, energy intake, tolerance Beker 1997 [] 5 mg/week oral vitamin K1. no supplementation 4 weeks 18 Stable, afebrile, without cholestasis/ overt liver disease, normal AST/ALT, normal albumin. Range: 13-35 years. Plasma vitamin K1, vitamin PIVKA-II, serum Osteocalcin, urinary GLA Van Egmond 1996 [] Predigested formula with 12% linoleic acid. Predigested formula with 7% linoleic acid. Not clear 76 Diagnosed by 9 mo, formula providing > 10% of intake ≥1 year Anthropometrics Stark 1995 [] Nutritional education+ mealtime behaviors. standard care 6 weeks 9 No specific inclusion. Range: 2-6 years. Calorie intake, weight gain Kurlandsky 1994 [] N-3 (menhaden oil 100-131 mg/kg/day, mean 112.8). N-6 (safflower oil mg/kg/day, mean 113.3). 6 weeks 14 Ability to pulmonary function + swallow capsules. Range: 6-16 years. Absorption and clinical effects of n-3 vs. n-6 fatty acids
MPG_2016_02_10_DAITCH_JPGN-15-367_SDC1.docx